Late-onset dementia is a major health concern in the ageing population. Alzheimer's
disease (AD) accounts for the largest proportion (65–70%) of dementia cases in the older …

Despite being a major global health concern, cerebral ischemia/stroke has limited
therapeutic options. Tissue plasminogen activator (tPA) is the only available medication to …

Epidemiological studies have proven that exposure to Arsenic (AS) leads to the
development of many neurological disorders. However, few studies have investigated its …

Background: Imaging amyloid-beta (Aβ) deposits with high fidelity in naturally aging brains
is crucial for the early diagnosis of Alzheimer's disease (AD). However, this is impeded by …

Higher prevalence of neurodegenerative diseases is strictly connected with progressive
aging of the world population. Interestingly, a broad range of age-related …

Age-related cognitive decline is the major cause of concern due to its 70% more incidence
than dementia cases worldwide. Moreover, aging is also the major risk factor of Alzheimer's …

Protein phosphorylation of serine, threonine, and tyrosine residues is one of the most
prevalent post-translational modifications fundamental in mediating diverse cellular …

Post-stroke edema and upregulation of aquaporin 4 (AQP4) water transport channels play a
significant role in the progression of stroke pathology and deteriorating stroke outcomes …

Alzheimer's disease (AD) is a neurodegenerative disorder, marked by cortical and
hippocampal deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles and cognitive …

For the maintenance of cellular homeostasis and energy metabolism, an uninterrupted
supply of oxygen (O 2) is routinely required in the brain. However, under the impaired level …